{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:07:50Z","timestamp":1778555270856,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-13-JF-53"],"award-info":[{"award-number":["1-13-JF-53"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL125877"],"award-info":[{"award-number":["R01HL125877"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL160927"],"award-info":[{"award-number":["R01HL160927"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.bbadis.2022.166414","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T11:32:35Z","timestamp":1650281555000},"page":"166414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["FGF1\u0394HBS delays the progression of diabetic nephropathy in late-stage type 2 diabetes mouse model by alleviating renal inflammation, fibrosis, and apoptosis"],"prefix":"10.1016","volume":"1868","author":[{"given":"Qian","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"John P.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HongXue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kupper A.","family":"Wintergerst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2022.166414_bb0005","first-page":"124","article-title":"Management of diabetic nephropathy in the elderly: special considerations","volume":"2","author":"Abdel-Rahman","year":"2012","journal-title":"J. Nephrol. Ther."},{"key":"10.1016\/j.bbadis.2022.166414_bb0010","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.dsx.2020.08.035","article-title":"A qualitative study exploring diabetes resilience among adults with regulated type 2 diabetes mellitus","volume":"14","author":"Kusnanto","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.bbadis.2022.166414_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jdiacomp.2011.11.002","article-title":"Self-efficacy, self-management, and glycemic control in adults with type 2 diabetes mellitus","volume":"26","author":"Al-Khawaldeh","year":"2012","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.bbadis.2022.166414_bb0020","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1497449","article-title":"Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment","volume":"2021","author":"Samsu","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbadis.2022.166414_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40842-016-0036-6","article-title":"Challenges in diagnosis and management of diabetes in the young","volume":"2","author":"Unnikrishnan","year":"2016","journal-title":"Clin. Diabetes Endocrinol."},{"key":"10.1016\/j.bbadis.2022.166414_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/962962","article-title":"A network map of FGF-1\/FGFR signaling system","volume":"2014","author":"Raju","year":"2014","journal-title":"J. Signal Transduction"},{"key":"10.1016\/j.bbadis.2022.166414_bb0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2022.166414_bb0040","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature10998","article-title":"A PPARgamma-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis","volume":"485","author":"Jonker","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2022.166414_bb0045","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature13540","article-title":"Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer","volume":"513","author":"Suh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2022.166414_bb0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.kint.2017.05.013","article-title":"Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism","volume":"93","author":"Liang","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2022.166414_bb0055","first-page":"1573","article-title":"MEK ablation in MCF-7 cells blocks DNA synthesis induced by serum, but not by estradiol or growth factors","volume":"29","author":"Estes","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbadis.2022.166414_bb0060","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1541-7786.MCR-11-0043","article-title":"Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells","volume":"9","author":"Liu","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbadis.2022.166414_bb0065","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1074\/jbc.273.12.6830","article-title":"Lysophosphatidylcholine stimulates the release of arachidonic acid in human endothelial cells","volume":"273","author":"Wong","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2022.166414_bb0070","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.celrep.2017.06.063","article-title":"Uncoupling the mitogenic and metabolic functions of FGF1 by tuning FGF1-FGF receptor dimer stability","volume":"20","author":"Huang","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2022.166414_bb0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41419-019-1696-9","article-title":"FGF1 (DeltaHBS) ameliorates chronic kidney disease via PI3K\/AKT mediated suppression of oxidative stress and inflammation","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2022.166414_bb0080","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/hep.31568","article-title":"Activating adenosine monophosphate-activated protein kinase mediates fibroblast growth factor 1 protection from nonalcoholic fatty liver disease in mice","volume":"73","author":"Lin","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2022.166414_bb0085","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/oby.21463","article-title":"Zinc delays the progression of obesity-related glomerulopathy in mice via down-regulating P38 MAPK-mediated inflammation","volume":"24","author":"Luo","year":"2016","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bbadis.2022.166414_bb0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7150\/ijbs.29063","article-title":"Clopidogrel reduces fibronectin accumulation and improves diabetes-induced renal fibrosis","volume":"15","author":"Zheng","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2022.166414_bb0095","article-title":"Sex differences in progression of diabetic nephropathy in OVE26 type 1 diabetic mice","volume":"2020","author":"Wang","year":"1866","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbadis.2022.166414_bb0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biopha.2018.10.041","article-title":"Protective effects of astragaloside IV on endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats","volume":"109","author":"Ju","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2022.166414_bb0105","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00125-015-3630-8","article-title":"Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1\/2-dependent signalling pathway","volume":"58","author":"Zhang","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2022.166414_bb0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2337\/dc07-1736","article-title":"Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study","volume":"31","author":"Monami","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2022.166414_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14740330802597821","article-title":"How safe is the use of thiazolidinediones in clinical practice?","volume":"8","author":"Rizos","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.bbadis.2022.166414_bb0120","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.cellsig.2013.07.007","article-title":"Induction of renal fibrotic genes by TGF-beta1 requires EGFR activation, p53 and reactive oxygen species","volume":"25","author":"Samarakoon","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2022.166414_bb0125","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.3390\/ijms20143598","article-title":"Cell death in the kidney","volume":"20","author":"Priante","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2022.166414_bb0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.kint.2016.03.026","article-title":"Prevention of apoptosis averts glomerular tubular disconnection and podocyte loss in proteinuric kidney disease","volume":"90","author":"Burlaka","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2022.166414_bb0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41419-020-2594-x","article-title":"Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy","volume":"11","author":"Jiang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2022.166414_bb0140","article-title":"The role of peroxisome proliferator-activated receptors in kidney diseases","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2022.166414_bb0145","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/path.2111","article-title":"Renal ageing","volume":"211","author":"Martin","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbadis.2022.166414_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/106384","article-title":"Effect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: a prespecified analysis of the benedict trial","volume":"2010","author":"Ruggenenti","year":"2010","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.bbadis.2022.166414_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: the link between insulin resistance, obesity and diabetes","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbadis.2022.166414_bb0160","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4239\/wjd.v5.i4.431","article-title":"Inflammation in diabetic kidney disease","volume":"5","author":"Garcia-Garcia","year":"2014","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.bbadis.2022.166414_bb0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11154-008-9100-6","article-title":"New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy","volume":"9","author":"Brosius","year":"2008","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bbadis.2022.166414_bb0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fendo.2013.00007","article-title":"Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis","volume":"4","author":"Kanasaki","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbadis.2022.166414_bb0175","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.3892\/mmr.2017.7522","article-title":"Alteration of oxidative stress and inflammatory cytokines induces apoptosis in diabetic nephropathy","volume":"16","author":"Sha","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2022.166414_bb0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2169\/internalmedicine.43.9","article-title":"Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure","volume":"43","author":"Nangaku","year":"2004","journal-title":"Intern. Med."},{"key":"10.1016\/j.bbadis.2022.166414_bb0185","article-title":"RIPK3-mediated necroptosis and apoptosis contributes to renal tubular cell progressive loss and chronic kidney disease progression in rats","volume":"11","author":"Zhu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2022.166414_bb0190","first-page":"1744","article-title":"TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and ras-dependent proliferation of cultured renal fibroblast","volume":"2013","author":"Ucero","year":"1832","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2022.166414_bb0195","doi-asserted-by":"crossref","first-page":"F4","DOI":"10.1152\/ajprenal.00045.2005","article-title":"Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction","volume":"290","author":"Docherty","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.bbadis.2022.166414_bb0200","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1124\/jpet.114.214205","article-title":"Astragaloside IV ameliorates renal fibrosis via the inhibition of mitogen activated protein kinases and antiapoptosis in vivo and in vitro","volume":"350","author":"Xu","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2022.166414_bb0205","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2119\/molmed.2015.00196","article-title":"Peroxisome proliferator-activated receptor alpha protects renal tubular cells from gentamicin-induced apoptosis via upregulating Na(+)\/H(+) exchanger NHE1","volume":"21","author":"Chen","year":"2016","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbadis.2022.166414_bb0210","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/ndt\/gfl212","article-title":"PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse","volume":"21","author":"Calkin","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbadis.2022.166414_bb0215","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.kint.2018.09.023","article-title":"ATF6alpha downregulation of PPARalpha promotes lipotoxicity-induced tubulointerstitial fibrosis","volume":"95","author":"Jao","year":"2019","journal-title":"Kidney Int."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922000849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922000849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:08:52Z","timestamp":1778551732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443922000849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0925443922000849"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166414","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FGF1\u0394HBS delays the progression of diabetic nephropathy in late-stage type 2 diabetes mouse model by alleviating renal inflammation, fibrosis, and apoptosis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166414"}}